Cargando…

P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales: Salomè, Mara, Campolungo, Daniele, Runfola, Valeria, Pannese, Maria, Carlet, Michela, Caronni, Claudia, Giambruno, Roberto, Ghirardi, Chiara, Jeremias, Irmela, Gabellini, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428239/
http://dx.doi.org/10.1097/01.HS9.0000968224.47489.ef
_version_ 1785090419778912256
author Salomè, Mara
Campolungo, Daniele
Runfola, Valeria
Pannese, Maria
Carlet, Michela
Caronni, Claudia
Giambruno, Roberto
Ghirardi, Chiara
Jeremias, Irmela
Gabellini, Davide
author_facet Salomè, Mara
Campolungo, Daniele
Runfola, Valeria
Pannese, Maria
Carlet, Michela
Caronni, Claudia
Giambruno, Roberto
Ghirardi, Chiara
Jeremias, Irmela
Gabellini, Davide
author_sort Salomè, Mara
collection PubMed
description
format Online
Article
Text
id pubmed-10428239
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104282392023-08-17 P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA Salomè, Mara Campolungo, Daniele Runfola, Valeria Pannese, Maria Carlet, Michela Caronni, Claudia Giambruno, Roberto Ghirardi, Chiara Jeremias, Irmela Gabellini, Davide Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428239/ http://dx.doi.org/10.1097/01.HS9.0000968224.47489.ef Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Salomè, Mara
Campolungo, Daniele
Runfola, Valeria
Pannese, Maria
Carlet, Michela
Caronni, Claudia
Giambruno, Roberto
Ghirardi, Chiara
Jeremias, Irmela
Gabellini, Davide
P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
title P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_full P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_fullStr P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_full_unstemmed P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_short P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
title_sort p328: characterization of a dux4-r inhibitor as a possible treatment for acute lymphoblastic leukemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428239/
http://dx.doi.org/10.1097/01.HS9.0000968224.47489.ef
work_keys_str_mv AT salomemara p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT campolungodaniele p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT runfolavaleria p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT pannesemaria p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT carletmichela p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT caronniclaudia p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT giambrunoroberto p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT ghirardichiara p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT jeremiasirmela p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia
AT gabellinidavide p328characterizationofadux4rinhibitorasapossibletreatmentforacutelymphoblasticleukemia